Catalyst
Slingshot members are tracking this event:
Phase 3 Nusinersen CHERISH trial data due in 2017
Do you think this event is important to the companies below? How will it affect their stock price?
Related Companies | Importance
|
Impact on Stocks
|
||||
---|---|---|---|---|---|---|
IONS |
|
|
Slingshot Insights Explained
Catalyst Date
Occurred on:
Apr 24, 2017
Occurred Source:
http://ir.ionispharma.com/phoenix.zhtml?c=222170&p=irol-newsArticle&ID=2263923
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 3 Nusinersen Trial, Cherish Trial, Spinal Muscular Atrophy, Sma, Endear Trial